Trial intelligence / Profile preview

TIVA vs Balanced Anesthesia in Colorectal Cancer Patients (CRS/HIPEC)

NCT05951842Withdrawn

Sponsor
Gangnam Severance Hospital
Start
Apr 2018
Primary completion
Feb 2020
Modality
Small Molecules
01

Overview

Randomised trial of propofol injection (veterinary) and sevoflurane in colorectal cancer (CRC) (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Postoperative immune function (NK cell count) at 1 day. Planned start Apr 2018; status: withdrawn.

02

Drugs

propofol injection (veterinary)sevoflurane
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT05951842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05951842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call